ARCHIVES

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz

March 29, 2013

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

September 20, 2013

NIH Updates Policy On Large Grants

May 10, 1996